Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

AIMS/INTRODUCTION: Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use is an ongoing postmarketing study of ipragliflozin for long‐term use in Japanese patients with type 2 diabetes mellitus. A subgroup analysis of data from the study was carried o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobe, Kazuyuki, Maegawa, Hiroshi, Tabuchi, Hiromi, Nakamura, Ichiro, Uno, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717900/
https://www.ncbi.nlm.nih.gov/pubmed/30719865
http://dx.doi.org/10.1111/jdi.13021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717900/
https://www.ncbi.nlm.nih.gov/pubmed/30719865
http://dx.doi.org/10.1111/jdi.13021

Ejemplares similares